New Findings on Potential Cardiovascular Biomarkers for Psoriatic Disease - Medpage Today

CTnI, NT-proBNP show promise, but don't outperform Framingham Risk Score

In a study of patients with psoriatic disease (PsD), the cardiac troponin I (cTnI) protein showed potential as a biomarker for subclinical atherosclerosis in this population. CTnI and the N-terminal … [+4567 chars]

full article...